Key result
Troponin-T ΔK210 mutation cuts cardiomyocyte force ~22% and drives cellular hypertrophy.
Why the study?
It is not well understood how sarcomeric protein mutations in familial DCM lead to alterations in cellular organization and contractility.
Population
Cardiomyocytes with a DCM mutation in troponin-T, ΔK210
Design
In vitro and computational modeling study
Authors
Loading...
Hypothesis-generating for mechanosensing in sarcomeric DCM; does not support clinical translation from this animal model.
Absolute Event Rate: 0.25% vs 0.32%
p-value: p=0.01
The ΔK210 mutation in troponin-T impairs mechanosensing and contractility in cardiomyocytes, providing a mechanistic link between molecular mutations and cellular phenotypes in familial dilated cardiomyopathy.
Clippinger et al. (2019) studied Familial dilated cardiomyopathy. ΔK210 mutation in troponin-T vs. Wild-type (WT) troponin-T was evaluated on Force per area (p=0.01). The ΔK210 mutation in troponin-T reduces cardiomyocyte force per area (0.25 vs 0.32 µN/µm2, p=0.01), causes cellular hypertrophy, and impairs adaptation to substrate stiffness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: